Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation

Armando Santoro, MD

Status: Unknown

Conditions: Lymphoma

Study type: Observational

Funder types: Other

Identifiers

NCT01891578

ONC/OSS-04/2010

Details and patient eligibility

About

Evaluation of immunological reconstitution after haploidentical BMT using a nonmyeloablative preparative regimen and post-transplant cyclophosphamide in patients with poor prognosis lymphoma

Enrollment: 23 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with lymphoma (any histology) relapsed after high dose chemotherapy and in partial remission, complete remission or stable disease after the last CT line that
• Signed informed consent to perform an haploidentical allo-BMT using a nonmyeloablative preparative regimen and post-transplant cyclophosphamide

Exclusion criteria

none